Acta Scientific Medical Sciences (ISSN: 2582-0931)

Case Report Volume 4 Issue 4

Pachydermoperiostosis in its Complete Family form

Thabet Maissa*, Ben Fredj Fatma, Adaily Najah, Anoun Jihed, Karme Ni Monia, Rezgui Amel and Laouani Cha Dia

Department of Internal Medicine, Sahloul Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia

*Corresponding Author: Thabet Maissa, Department of Internal Medicine, Sahloul Hospital, University of Sousse, Faculty of Medicine of Sousse, Tunisia.

Received: February 21, 2020; Published: March 12, 2020

×

Abstract

Introduction: Pachydermoperiostosis (PDP) or primary hypertrophic osteoarthropathy (OAH) is a rare hereditary disorder. We report the case of a family with PDP in its complete form. 

Clinical case: We report the case of a 25-year-old man suffering from polyarthralgia with palmoplantar hypertrophy. Its history began in 2015 with the progressive installation of diffuse polyarthralgia more pronounced in large joints (knees, ankles, elbows) with diffuse bone pain and a history of pathological fracture of the left 3 metatarsal without trauma. The patient described hyper sudation, seborrhoea and increased thickening of the forehead folds and palmoplantar hypertrophy during the last 3 years. Skin examination noted oily skin, glistening and puffy, pachydermia of the extremities with a pleated thickening of the forehead, without ptosis. Palmoplantar hypertrophy and digital clubbing were evident with pudgy fingers and toes. The patient shod 44 against 41 three years ago. The clinical examination also found palmoplantar hyperhidrosis and free joints, with no inflammatory signs. The diagnosis of PDP was retained, and the patient was put on colchicine. We noted consanguinity of the parents and the physical examination of the other members of the family found the same manifestations in the father and the brother with variable intensity. 

Conclusion: PDP is a benign genetic affection that primarily affects the skin and bones. Its pathophysiological mechanism remains unclear. 

Keywords: Pachydermoperiostosis; Primary Hypertrophic Osteoarthropathy; Cutis Verticis Gyrate

×

References

  1. Auger M and Stavrianeas N. “Pachydermoperiostosis”. Orphanet Encyclopedia (2004). 
  2. Ben Hamida SK., et al. “Primary hypertrophic osteoarthropathy without skin involvement (Currarino disease)”. La Presse Médicale 32 (2003): 1455-1456. 
  3. F Kabi., et al. “Pachydermoperiostosis. About a case”. Revue de Médecine Interne 27 (2006): 710-712.
  4. Combemale P., et al. “Pachydermoperiostosis: Ultrastructural study”. Annales de Dermatologie et de Vénéréologie 121 (1994): 893 -897. 
  5. Sinha GP., et al. “Pachydermoperiostosis in childhood”. British Journal of Rheumatology 36 (1997): 1224 -1227.
  6. Bouldouyre MA and Steff M. “Pachyderm operiostosis”. La Presse Médicale (2014).
  7. Borochowitz Z and Limoind DL. “Pachydermoperiostosis”. Birth Defect Encyclopaedie (1990): 1349 -1350. 
  8. Touraine A., et al. “An osteodermopathic syndrome: Plicated pachydermia with periostosis of the extremities”. La Presse Médicale 43 (1935): 1820-1824.
  9. Gaston- Carrette F., et al. “About a case of Currarino disease (primary hypertrophic osteoarthropathy without skin involvement)”. Revue Du Rhumatisme 65 (1998): 653-5. 
  10. L Rezgui - Marhoul., et al. “Pachydermoperiostosis: about two cases”.  European Journal of Radiology 86 (2005): 340-343. 
  11. Guyot-Drouot Mh., et al. “Rhumatologic manifestations of pachydermoperiostosis and preliminary experience with bisphosphonates”. European Journal of Radiology 27 (2000): 2418 -2423. 
  12. Yap FY., et al. “Hypertrophic Osteoarthropathy: Clinical and Imaging Features”. Radiographics 37.1 (2017): 157-195.
  13. Zhang H and Yang B. “Successful treatment of pachydermoperiostosis patients with etoricoxib, aescin, and arthroscopic synovectomy: Two case reports”. Medicine 96.47 (2017): e8865.
×

Citation

Citation: Thabet Maissa., et al. “Pachydermoperiostosis in its Complete Family form". Acta Scientific Medical Sciences 4.4 (2020): 56-59.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





Contact US